Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Intra-Cellular Therapies, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ITCI
Nasdaq
2830
www.intracellulartherapies.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Intra-Cellular Therapies, Inc.
Steady M&A Deals to Begin 2025, Disappointing IPOs So Far
- Feb 5th, 2025 2:59 pm
Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now
- Jan 26th, 2025 8:27 am
Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now
- Jan 24th, 2025 11:28 am
Biotech Venture Investors Optimistic, But Uncertainties Persist
- Jan 23rd, 2025 8:40 pm
Johnson & Johnson (JNJ) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...
- Jan 23rd, 2025 7:02 am
Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe Wolk
- Jan 22nd, 2025 5:03 pm
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
- Jan 22nd, 2025 3:22 pm
Why Intra-Cellular Therapies, Inc. (ITCI) Dominated Last Week’s Rally
- Jan 19th, 2025 6:00 pm
Jim Cramer on Intra-Cellular Therapies, Inc. (ITCI): ‘Intra-Cellular Had Something’
- Jan 19th, 2025 2:42 am
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales
- Jan 17th, 2025 8:00 pm
J&J's AAA Rating in Jeopardy as Acquisition Sparks Debt Concerns
- Jan 15th, 2025 4:00 pm
J&J’s Top Rating at Risk Because of Intra-Cellular Deal
- Jan 15th, 2025 3:16 pm
The Zacks Analyst Blog Highlights J&J, Eli Lilly, GSK and Intra-Cellular
- Jan 15th, 2025 9:23 am
JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
- Jan 14th, 2025 8:00 pm
J&J to leverage Intra-Cellular Therapies’ neurology portfolio
- Jan 14th, 2025 5:13 pm
Why Intra-Cellular (ITCI) Led the Monday Upsurge?
- Jan 14th, 2025 2:53 pm
ITCI Poised for Turnaround Amid Rising Mental Health Concerns
- Jan 14th, 2025 1:56 pm
Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer
- Jan 14th, 2025 1:54 pm
Intra-Cellular (ITCI) Moves 34.1% Higher: Will This Strength Last?
- Jan 14th, 2025 11:58 am
ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan
- Jan 14th, 2025 10:51 am
Scroll